I agree that this site is using cookies. You can find further informations here.
X
Hiret, S.
53  results:
Search for persons X
?
1

Clinical characteristic and survival outcomes of patients w..:

Thomas, Q.D. ; Quantin, X. ; Lemercier, P....
ESMO Open.  9 (2024)  6 - p. 103473 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Correction to: Real-world multicentre cohort of first-line ..:

Pons-Tostivint, E. ; Hulo, P. ; Guardiolle, V....
Cancer Immunology, Immunotherapy.  72 (2023)  6 - p. 1891-1892 , 2023
Link: https://doi.org/10.1007/..
 
?
3

Real-world multicentre cohort of first-line pembrolizumab a..:

Pons-Tostivint, E. ; Hulo, P. ; Guardiolle, V....
Cancer Immunology, Immunotherapy.  72 (2023)  6 - p. 1881-1890 , 2023
Link: https://doi.org/10.1007/..
 
?
4

OA21.04 Amivantamab in Patients with Advanced NSCLC and MET..:

Leighl, N. ; Cho, B.C. ; Hiret, S....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S93-S94 , 2023
Link: https://doi.org/10.1016/..
 
?
5

Reduced risk of secondary primary extra pulmonary cancer in..:

Heudel, P.E. ; de Montfort, A. ; Debieuvre, D....
Lung Cancer.  182 (2023)  - p. 107280 , 2023
Link: https://doi.org/10.1016/..
 
?
6

First-line nivolumab plus ipilimumab versus chemotherapy in..:

Peters, S. ; Scherpereel, A. ; Cornelissen, R....
Annals of Oncology.  33 (2022)  5 - p. 488-499 , 2022
Link: https://doi.org/10.1016/..
 
?
7

Real-world overview of therapeutic strategies and prognosis..:

Cabart, M. ; Mourey, L. ; Girard, N....
Journal of Geriatric Oncology.  12 (2021)  8 - p. S3 , 2021
Link: https://doi.org/10.1016/..
 
?
8

Continuation versus discontinuation of first-line chemother..:

Adenis, A. ; Bennouna, J. ; Etienne, P.L....
European Journal of Cancer.  111 (2019)  - p. 12-20 , 2019
Link: https://doi.org/10.1016/..
 
?
9

Sclérose dermo-hypodermique des membres induite par le pémé..:

Soenen, A. ; Hiret, S. ; Peuvrel, L...
Annales de Dermatologie et de Vénéréologie.  146 (2019)  12 - p. A154 , 2019
Link: https://doi.org/10.1016/..
 
?
10

Pustulose palmoplantaire unilatérale sous avélumab:

Marsan, F.M. ; Hiret, S. ; Saint Jean, M..
Annales de Dermatologie et de Vénéréologie.  146 (2019)  12 - p. A152-A153 , 2019
Link: https://doi.org/10.1016/..
 
?
11

Tumeurs neuro-endocrines pancréatiques et syndrome d'hypers..:

Le Bras, M. ; Cariou, B. ; Dupas, B....
Annales d'Endocrinologie.  76 (2015)  4 - p. 512 , 2015
Link: https://doi.org/10.1016/..
 
?
12

3128 EGFR, ALK, KRAS prognostic value in a large French pro..:

Cadranel, J. ; Quoix, E. ; Duruisseaux, M....
European Journal of Cancer.  51 (2015)  - p. S646 , 2015
Link: https://doi.org/10.1016/..
 
?
13

2349 Phase 1b/2 study results for masitinib plus irinotecan..:

Zaanan, A. ; Bennouna, J. ; Hiret, S....
European Journal of Cancer.  51 (2015)  - p. S451 , 2015
Link: https://doi.org/10.1016/..
 
?
14

Phase I dose-escalation study of oral vinflunine in combina..:

Krzakowski, M. ; Bennouna, J. ; Dansin, E....
Cancer Chemotherapy and Pharmacology.  73 (2013)  2 - p. 231-236 , 2013
Link: https://doi.org/10.1007/..
 
?
15

Phase I dose-escalation study of vinflunine hard capsules a..:

Calvo, E. ; Vermorken, J. B. ; Hiret, S....
Cancer Chemotherapy and Pharmacology.  69 (2012)  6 - p. 1467-1475 , 2012
Link: https://doi.org/10.1007/..
 
1-15